title: Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment.
abstract: Monitoring renal function and adjusting dosing for patients with impaired renal function are not required with denosumab (60 mg every 6 months). However, these patients have an increased risk for developing hypocalcemia. This case report describes a patient with renal impairment who developed severe hypocalcemia after receiving denosumab.
authors.affiliation: Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, CAUSA.
authors.forename: Draupadi B
authors.initials: DB
authors.lastname: Talreja
keywords: Denosumab; Hypocalcemia; Renal impairment; Safety